cyclosporine has been researched along with Vitiligo in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Niaimi, F; Ali, FR; Searle, T | 1 |
| Chen, Y; Hu, Y; Lu, H; Luo, H; Song, X; Xie, B; Xu, J | 1 |
| Bishnoi, A; Kumar, S; Kumaran, MS; Mehta, H; Parsad, D; Vinay, K | 1 |
| Khoja, M; Mutalik, S; Shah, S; Sidwadkar, V | 1 |
| Busmanis, I; Lee, HY; Lian, BS | 1 |
| Abboud, M; Locatelli, F; Muwakkit, S; Razzouk, B; Wilimas, J | 1 |
| Fabbri, P; Terranova, M; Torchia, D | 1 |
1 review(s) available for cyclosporine and Vitiligo
| Article | Year |
|---|---|
Vitiligo: an update on systemic treatments.
Topics: Administration, Oral; Administration, Topical; Adrenal Cortex Hormones; alpha-MSH; Anti-Bacterial Agents; Calcineurin Inhibitors; Combined Modality Therapy; Cyclosporine; Dermatologic Agents; Humans; Janus Kinase Inhibitors; Methotrexate; Minocycline; Neoadjuvant Therapy; Outcome Assessment, Health Care; Phototherapy; Psychology; Vitiligo | 2021 |
1 trial(s) available for cyclosporine and Vitiligo
| Article | Year |
|---|---|
Oral cyclosporine is effective in stabilizing active vitiligo: Results of a randomized controlled trial.
Topics: Administration, Oral; Cyclosporine; Dexamethasone; Humans; Quality of Life; Treatment Outcome; Vitiligo | 2021 |
5 other study(ies) available for cyclosporine and Vitiligo
| Article | Year |
|---|---|
The multi-target mechanism of Cyclosporin A in the treatment of vitiligo based on network pharmacology.
Topics: Cyclosporine; Drugs, Chinese Herbal; Gene Ontology; Humans; Molecular Docking Simulation; Vitiligo | 2021 |
Efficacy of Cyclosporine After Autologous Noncultured Melanocyte Transplantation in Localized Stable Vitiligo-A Pilot, Open Label, Comparative Study.
Topics: Adolescent; Adult; Aged; Child; Combined Modality Therapy; Cyclosporine; Dermatologic Agents; Female; Humans; Male; Melanocytes; Middle Aged; Pilot Projects; Prospective Studies; Transplantation, Autologous; Treatment Outcome; Vitiligo | 2017 |
Relapsing Course of Sulfasalazine-Induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Complicated by Alopecia Universalis and Vitiligo.
Topics: Alopecia; Antirheumatic Agents; Arthritis, Rheumatoid; Biopsy; Cyclosporine; Dermatologic Agents; Drug Hypersensitivity Syndrome; Humans; Male; Middle Aged; Prednisolone; Skin; Sulfasalazine; Symptom Flare Up; Treatment Outcome; Vitiligo | 2018 |
Report of a child with vitiligo and Evans syndrome.
Topics: Anemia, Hemolytic, Autoimmune; Antibodies, Anticardiolipin; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Autoimmune Diseases; Child, Preschool; Cyclosporine; Eczema; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Infections; Male; Milk Hypersensitivity; Prednisone; Rituximab; Salmonella Infections; Syndrome; Thrombocytopenia; Vitiligo; Zidovudine | 2003 |
Photosensitive psoriasis in a vitiligo patient.
Topics: Adolescent; Cyclosporine; Dermatitis, Exfoliative; Dermatologic Agents; Female; Humans; Immunosuppressive Agents; Photosensitivity Disorders; Psoriasis; Sunlight; Vitiligo | 2006 |